Ipamorelin
hormonal compound
Ipamorelin is a synthetic ghrelin mimetic engineered to selectively stimulate endogenous growth hormone secretion. Its high receptor specificity ensures robust pulsatile release without the typical side effects associated with non-selective secretagogues.
Research Areas
Mechanism of Action
It acts as a selective agonist at the ghrelin receptor, triggering pulsatile growth hormone release through the hypothalamus and pituitary axis.
Biological Pathways
Areas of Research Interest
Potential effects under study. Not all are established in humans.
- •Enhanced endogenous growth hormone secretion
- •Accelerated muscle fiber recovery
- •Improved sleep architecture and quality
- •Supports healthy body composition
Risks & Cautions
Ipamorelin is classified as higher complexity. This is a relative educational classification, not a determination of safety. Effects, adverse events and long-term data may be incomplete. Speak with a licensed healthcare professional about any individual decision.
Evidence & Research References
STACKWELL classification: Moderate Evidence. Classifications are editorial and are never influenced by commercial relationships.
Related Content
Frequently Asked Questions
Community Discussion
Questions and experiences from members. Community posts are anecdotes, not clinical evidence.
Discuss IpamorelinEducational content only. STACKWELL summarizes published research and does not provide individualized medical advice. Some compounds discussed may be investigational or not approved for human use in your jurisdiction. STACKWELL does not recommend, prescribe or dose any compound, and this content is not a substitute for care from a qualified healthcare professional.